METHYL SALICYLATE
Methyl 2-hydroxybenzoate
METHYL SALICYLATE is listed in Annex III and may only be used under the conditions shown in this record. Maximum concentration in this record: (a) 0,06 % (b) 0,05 % (c) 0,002 % (d) 0,009 % (e) 0,003 % (f) 0,04 % (g) 0,06 % (h) 0,6 % (i) 0,6 % (j) 0,03 % (k) 2,52 % (l) 0,1 % (m) 0,6 % (n) 0,65 %.
Record details
Maximum concentration
(a) 0,06 % (b) 0,05 % (c) 0,002 % (d) 0,009 % (e) 0,003 % (f) 0,04 % (g) 0,06 % (h) 0,6 % (i) 0,6 % (j) 0,03 % (k) 2,52 % (l) 0,1 % (m) 0,6 % (n) 0,65 %
Product type
Other restrictions
Not to be used in preparations for children under 6 years of age, with the exception of (k) “Toothpaste”. The presence of the substance shall be indicated in the list of ingredients referred to in Article 19(1), point (g), when its concentration exceeds: — 0,001 % in leave-on products — 0,01 % in rinse-off products.
INCI glossary name
METHYL SALICYLATE
Chemical name
Methyl 2-hydroxybenzoate
Chemical / IUPAC name
Methyl 2-hydroxybenzoate
Regulatory information
Regulation
(EU) 2023/1545
Identified ingredients
CMR
| Category | Carcinogenic | Mutagenic | Reprotoxic |
|---|---|---|---|
| Cat. 2 | — | — | ✓ |
Key data
Inventory links for METHYL SALICYLATE
Related records for METHYL SALICYLATE
Direct matches are limited for this record, so nearby entries from Annex III are shown as well.
POTASSIUM CHLORATE / SODIUM CHLORATE
TITANIUM DIOXIDE
What Annex III means for METHYL SALICYLATE
METHYL SALICYLATE is a restricted substance under Annex III of EU Cosmetics Regulation 1223/2009. Its use in cosmetics is only permitted under the specific conditions set out in the entry above, including applicable concentration limits, product type restrictions and required warning statements.
When including this substance in a formulation, all conditions — maximum concentration, product scope and warning labels — must be met simultaneously. Compliance with one condition does not override the others.
This record is linked to 1 CosIng inventory ingredient for name and identifier cross-reference. The page also surfaces 11 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Ensure formulation concentration does not exceed: (a) 0,06 % (b) 0,05 % (c) 0,002 % (d) 0,009 % (e) 0,003 % (f) 0,04 % (g) 0,06 % (h) 0,6 % (i) 0,6 % (j) 0,03 % (k) 2,52 % (l) 0,1 % (m) 0,6 % (n) 0,65 %
- Confirm product type compatibility: (a) Leave-on skin products (except face makeup, spray/aerosol body lotion, spray/aerosol deodorant and hydroalcoholic-based fragrances) and leave on hair products (except spray/aerosol products) (b) Face makeup (except lip products, eye makeup and makeup remover) (c) Eye makeup and makeup remover (d) Leave-on hair products (spray/aerosol) (e) Deodorant spray/aerosol (f) Body lotion spray/aerosol (g) Rinse-off skin products (except hand wash) and rinse-off hair products (h) Hand wash (i) Hydroalcoholic-based fragrances (j) Lip products (k) Toothpaste (l) Mouthwash intended for children aged 6–10 years (m) Mouthwash intended for children above 10 years of age and adults (n) Mouth spray
- Document conditions of use in the Product Information File (PIF).
- This substance has CMR classification. Review the CMR table above and verify current Annex II/III status before use.
Frequently asked questions
Source note for Annex III record METHYL SALICYLATE
This page summarizes one Annex III record for METHYL SALICYLATE from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex III conditions for METHYL SALICYLATE, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect METHYL SALICYLATE and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare METHYL SALICYLATE side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex III and compare regulatory conditions across substances in this annex.
Open Annex III